SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017083
Filing Date
2023-05-15
Accepted
2023-05-15 12:17:34
Documents
55
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 515268
2 ex31-1.htm EX-31.1 17182
3 ex31-2.htm EX-31.2 17108
4 ex32-1.htm EX-32.1 9312
  Complete submission text file 0001493152-23-017083.txt   2904566

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE biaf-20230331.xsd EX-101.SCH 23381
6 XBRL CALCULATION FILE biaf-20230331_cal.xml EX-101.CAL 43511
7 XBRL DEFINITION FILE biaf-20230331_def.xml EX-101.DEF 93903
8 XBRL LABEL FILE biaf-20230331_lab.xml EX-101.LAB 216646
9 XBRL PRESENTATION FILE biaf-20230331_pre.xml EX-101.PRE 170701
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 276515
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41463 | Film No.: 23920110
SIC: 8731 Services-Commercial Physical & Biological Research